The HRA works at the interface between Biophytis and the regulatory authorities, through the entire life cycle of the medication, from early development, to commercialization. He/She has an up-to-date knowledge of the regulatory guidelines, a good understanding of the decision-making process in the regulatory authorities and is able to identify trends and directions that influence this process.
The HRA serves as the contact person of Biophytis with the regulatory authorities and is managing the documentation required for all steps of development and commercialization. The HRA is also a ‘center of excellence’, for knowledge and advice, to inform and direct the development and commercialization plans.
The position is located in Paris, France, and provides a global coverage. The HRA reports to the Chief medical officer (CMO) and works in close links with the clinical and medical directors, as well as Project Leaders and with the relevant functions throughout the organization. A relatively significant amount of travel is also required (+/-30%).